Karonudib is a promising anticancer therapy in hepatocellular carcinoma
DOI: 10.1177/1758835919866960
Azita Rasti,
Camilla Gokturk,
Helge Gad,
Jianjun Zhang,
Kang He,
Kumar Sanjiv,
Mingxuan Feng,
Qiang Xia,
Therese Pham,
Thomas Helleday,
Ulrika Warpman Berglund,
Xiangwei Hua,
Yunjin Zang,
Zhenjun Zhao
Keywords: cancer, cancer treatment, hepatocellular carcinoma, MTH1, reactive oxygen species
Abstract:
Full-Text
